Divergent amino acid and sphingolipid metabolism in patients with inherited neuro-retinal disease.
Divergent amino acid and sphingolipid metabolism in patients with inherited neuro-retinal disease.
复制标题
遗传性神经视网膜疾病患者的不同氨基酸和鞘脂代谢。
DOI:
10.1016/j.molmet.2023.101716
复制
发表时间:
2023
影响因子:
8.1
通讯作者:
中科院分区:
文献类型:
--
作者:
Green,CourtneyR;Bonelli,Roberto;Ansell,BrendanRE;Tzaridis,Simone;Handzlik,MichalK;McGregor,GraceH;Hart,Barbara;Trombley,Jennifer;Reilly,MaryM;Bernstein,PaulS;Egan,Catherine;Fruttiger,Marcus;Wallace,Martina;Bahlo,Melanie;
ObjectivesThe non-essential amino acids serine, glycine, and alanine, as well as diverse sphingolipid species, are implicated in inherited neuro-retinal disorders and are metabolically linked by serine palmitoyltransferase (SPT), a key enzyme in membrane lipid biogenesis. To gain insight into the pathophysiological mechanisms linking these pathways to neuro-retinal diseases we compared patients diagnosed with two metabolically intertwined diseases: macular telangiectasia type II (MacTel), hereditary sensory autonomic neuropathy type 1 (HSAN1), or both.MethodsWe performed targeted metabolomic analyses of amino acids and broad sphingolipids in sera from a cohort of MacTel (205), HSAN1 (25) and Control (151) participants.ResultsMacTel patients exhibited broad alterations of amino acids, including changes in serine, glycine, alanine, glutamate, and branched-chain amino acids reminiscent of diabetes. MacTel patients had elevated 1-deoxysphingolipids but reduced levels of complex sphingolipids in circulation. A mouse model of retinopathy indicates dietary serine and glycine restriction can drive this depletion in complex sphingolipids. HSAN1 patients exhibited elevated serine, lower alanine, and a reduction in canonical ceramides and sphingomyelins compared to controls. Those patients diagnosed with both HSAN1 and MacTel showed the most significant decrease in circulating sphingomyelins.ConclusionsThese results highlight metabolic distinctions between MacTel and HSAN1, emphasize the importance of membrane lipids in the progression of MacTel, and suggest distinct therapeutic approaches for these two neurodegenerative diseases.